Example: Heart Attack

Search clinical trials for: Machine learning algorithm

Total 10000 results

NCT05858450

Completed

This Study Intends to Describe the Characteristics of Patients Given the Pfizer-BioNTech Bivalent mRNA COVID-19 Vaccine and Any Commercially Available Influenza Vaccines at the Same Time Versus at Different Times.

COVID-19 | Influenza, Human
NCT04969601

Completed

Anti-Covid-19 Vaccine in Children With Acute Leukemia and Their Siblings (PACIFIC)

Acute Myeloid Leukemia | Acute Lymphoblastic Leukemia | Acute Leukemia
NCT04981717

Terminated

A Study to Examine the Efficacy and Safety of Anti-Fel d 1 Antibodies Injections in Cat-allergic Adolescent and Adult Patients With Allergic Rhinitis Who Live With a Cat

Allergic Rhinitis Due to Cat Allergy
NCT04747522

Active, not recruiting

Severe Acute Respiratory Syndrome Corona Virus 2 (SARS-CoV-2) Immune Kidney Transplant Study (COVID-19) (SCV-KTx-imm)

Kidney Transplant Infection | SARS-CoV Infection
NCT05913024

Completed

Immunogenicity and Safety of Enterovirus Type 71 Vaccine,Inactivated(Vero Cells) in Volunteers Aged From 6 to 71 Months

Healthy Volunteers
NCT00583752

Completed

Phase II Study of Adenovirus/PSA Vaccine in Men With Recurrent Prostate Cancer After Local Therapy APP21 (APP21)

Recurrent Prostate Cancer
NCT00278200

Terminated

Vaccine Therapy For Patients Being Considered For Organ Transplant Who Are at Risk For PTLD

Lymphoproliferative Disorder
NCT05115019

Withdrawn

A Clinical Trial to Evaluate the Efficacy of RUTI® to Reduce the Severity of SARS-CoV-2 Infection (COVID-19)

COVID-19
NCT04449276

Completed

A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of Vaccine CVnCoV in Healthy Adults for COVID-19

Severe Acute Respiratory Syndrome | COVID-19 | SARS-CoV-2 | Coronavirus
NCT04903184

Completed

Exploratory Study to Evaluate the Efficacy of RUTI® Against SARS-COV-2 Infection (COVID-19) in Healthcare Workers

Covid-19
NCT04793620

Terminated

Pertussis Acellular Vaccine Adjuvanted With TQL1055

Pertussis
NCT00623831

Completed

A Phase 1 Study of Mixed Bacteria Vaccine (MBV) in Patients With Tumors Expressing NY-ESO-1 Antigen

Melanoma | Sarcoma | Breast Cancer | Head and Neck Cancer | Esophageal Cancer | Transitional Cell Carcinoma | Prostate Cancer | Ovarian Carcinoma | Gastrointestinal Stromal Tumor (GIST)
NCT04936997

Completed

Immune Response to the COVID-19 Vaccine

Cancer | Covid19 | Malignancy | Vaccine Response Impaired
NCT04297436

Completed

Gonococcal Vaccine Study in Key Populations in Kenya (BexKPK)

Gonorrhea
NCT03442582

Completed

Afluria Pregnancy Registry

Pregnancy | Influenza, Human | Birth Defect
NCT00001125

Completed

Use of a Varicella-Zoster Virus (VZV) Vaccine to Prevent Shingles in HIV-Infected Children Who Have Already Had Chickenpox

HIV Infections | Chickenpox
NCT00000837

Completed

A Study of the Safety and Effectiveness of a Chickenpox Vaccine in HIV-Infected Children

HIV Infections
NCT00550225

Completed

Succinate Salt Version of GSK961081 for Healthy Volunteers

Pulmonary Disease, Chronic Obstructive
NCT03145324

Completed

Immunisation History Survey - a Study to Measure Levels of Immunity to Routine Immunisations

Immunization; Infection
NCT05060861

Active, not recruiting

Safety, Efficacy of Chadox1 Ncov-19 Vaccine: Rapid Systematic Review and Meta Analysis

ChAdOx1 nCoV-19 Vaccine
NCT04385524

Withdrawn

Use of Dynavax Heplisav B in Healthcare Workers Previously Vaccinated With 3-dose Vaccine Who Failed to Demonstrate Seroprotection

Hepatitis B Virus
NCT03051386

Active, not recruiting

Safety and Immunogenicity of Venezuelan Equine Encephalomyelitis Vaccine in Healthy Adults (VEE)

Venezuelan Equine Encephalomyelitis Virus Disease
NCT02451332

Completed

Prenatal Inflammation and Perinatal Outcomes

Pregnancy
NCT02601612

Completed

Safety and Immunogenicity of the RSV D46cpΔM2-2 Vaccine in RSV-Seropositive Children and RSV-Seronegative Infants and Children

Respiratory Syncytial Virus Infections
NCT03564444

Completed

D2560C00015 FluMist Annual Safety Study 2018

Healthy | Influenza
NCT00395135

Completed

BLOOM: Behavioral Modification and Lorcaserin for Overweight and Obesity Management

Obesity
NCT02176746

Completed

A Phase I/II Study of Active Immunotherapy With Cancer Stem Cells Vaccine for Colorectal Cancer (CSC)

Neoplasms,Colorectal
NCT02144610

Terminated

Efficacy and Safety of AMG0001 in Subjects With Critical Limb Ischemia (AGILITY)

Critical Limb Ischemia
NCT03163342

Completed

Immune Response Following Seasonal Influenza Vaccination

Influenza
NCT00975884

Completed

Study to Evaluate Immunogenicity & Safety of an Investigational Influenza Vaccine in Adults

Influenza
NCT01522248

Completed

Early Immune Responses to Inactivated Influenza Vaccine: a Pilot Study

Influenza Virus Vaccine
NCT03871205

Unknown

Neoantigen-primed DC Vaccines Therapy for Refractory Lung Cancer

Carcinoma, Non-Small Cell Lung | Carcinoma, Small Cell Lung
NCT03468244

Unknown

Clinical Study of Personalized mRNA Vaccine Encoding Neoantigen in Patients With Advanced Digestive System Neoplasms

Pancreatic Adenocarcinoma | Gastric Adenocarcinoma | Colorectal Adenocarcinoma | Advanced Esophageal Squamous Carcinoma
NCT03270800

Completed

Phase 1a/b Study on Safety of IMX101 in H. Pylori-negative and H. Pylori-infected Healthy Volunteers (IMX-02)

Helicobacter Pylori Infected Subjects | Helicobacter Pylori Naive Subjects
NCT00460525

Completed

Phase II AMA-1 Malaria Vaccine FMP2.1/AS02A Trial in Mali

Plasmodium Falciparum Malaria
NCT01777321

Completed

Safety and Immunogenicity Study of GSK Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine GSK1437173A When Administered Subcutaneously Intramuscularly in Adults Aged ≥50 Years

Herpes Zoster
NCT01751165

Completed

Safety and Immunogenicity of Different Dosing Schedules of GlaxoSmithkline (GSK) Biologicals' Herpes Zoster (HZ) Vaccine in Adults 50 Years of Age or Older

Herpes Zoster
NCT00964951

Withdrawn

CSL H1N1 Influenza Vaccine Administered at Different Dose Levels With and Without AS03 Adjuvant in Healthy Adult and Elderly Populations

Influenza
NCT02049489

Completed

A Study of ICT-121 Dendritic Cell Vaccine in Recurrent Glioblastoma

Glioblastoma Multiforme
NCT03186430

Completed

PreTeenVax Evaluation

Human Papilloma Virus
NCT02725437

Completed

Clostridium Difficile Vaccine Safety, Tolerability, and Immunogenicity Study in Japanese Adults

Clostridium Difficile Associated Disease
NCT02844088

Completed

Evaluation of Vaccinal and Natural Immunity Against Meningococcus C

Prevention of Meningococcus C Infections
NCT00316654

Completed

Persistence of Antibody Response to N. Meningitidis Group C in Children

Prevention of Meningococcal Infection
NCT00945841

Completed

Safety and Immunogenicity, Inactivated Split Influenza Vaccine, Using the Strain Composition 2009/2010

Seasonal Influenza
NCT02186626

Completed

Evaluating the Safety and Immunogenicity of a Live Attenuated West Nile Virus Vaccine for West Nile Encephalitis in Adults 50 to 65 Years of Age

West Nile Virus
NCT00848029

Completed

Safety and Immunogenicity of Two Doses of Monovalent Inactivated Influenza Vaccine That is Adjuvanted With MF59C.1 (MF59) and Uses a Surface Antigen From a Potential Pandemic Virus Strain Candidate (H5N1) in Adult and Elderly Subjects Using Four Different Vaccination Schedules

Pre-pandemic Influenza Vaccine
NCT00452686

Completed

Study to Assess Safety & Immunogenicity of GSK Biologicals' Boostrix (dTpa) Vaccine vs. Chinese DT Vaccine

Tetanus | Diphtheria | Acellular Pertussis
NCT00850785

Completed

Autologous Tumor DRibble Vaccine in Patients With Non-Small Cell Lung Cancer (DRibble)

Non Small Cell Lung Cancer
NCT00370864

Completed

Study of a Pandemic Influenza Vaccine in Children

Influenza
NCT00376402

Completed

Study of a Pandemic Influenza Vaccine in Elderly Participants

Influenza

Search clinical trials for: Machine learning algorithm

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations